Presenters Discuss: how modeling the potential impact of an AIDS vaccine can help policymakers and advocates make better decisions about the importance of sustaining commitment to research and developing strategies for eventual rollout and access (Kenya and Uganda); the results of a study modeling the impact of AIDS vaccines of various efficacy and under different rollout scenarios in Brazil, and an overview of how these modeling results can be useful to policymakers in understanding partial efficacy, targeted vaccination strategies, prioritizing prevention research and considering future access issues (Brazil); and how computer simulation and modeling tools such as the Spectrum Package can be used to model the impact of an AIDS vaccine and assist policymakers in preparing for the introduction of new prevention technologies that are still in development, the Spectrum package and the vaccine module and the key assumptions underlying the model (Global).
